Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
2 "Ju Yeon Yang"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Articles
Factors Associated for Mild Cognitive Impairment in Older Korean Adults with Type 2 Diabetes Mellitus
Yun Jeong Lee, Hye Mi Kang, Na Kyung Kim, Ju Yeon Yang, Jung Hyun Noh, Kyung Soo Ko, Byoung Doo Rhee, Dong-Jun Kim
Diabetes Metab J. 2014;38(2):150-157.   Published online April 18, 2014
DOI: https://doi.org/10.4093/dmj.2014.38.2.150
  • 4,682 View
  • 38 Download
  • 22 Web of Science
  • 25 Crossref
AbstractAbstract PDFPubReader   
Background

The aim of this study was to identify factors associated with mild cognitive impairment (MCI) in older Korean adults with type 2 diabetes mellitus.

Methods

A total of 226 older (age ≥65 years) adults without a history of cerebrovascular disease or dementia participated in this study. Cognitive function was assessed with the Montreal Cognitive Assessment-Korean version (MoCA-K). A MoCA-K score <23 was defined as MCI.

Results

The prevalence of MCI was 32.7%. In a logistic regression analysis, age (≥74 years old vs. 65-68 years old; odds ratio [OR], 3.69; 95% confidence interval [CI], 1.55 to 8.82; P=0.003), educational background (college graduation vs. no school or elementary school graduation; OR, 0.16; 95% CI, 0.05 to 0.46; P=0.001), and systolic blood pressure (≥135 mm Hg vs. ≤120 mm Hg; OR, 3.25; 95% CI, 1.29 to 8.17; P=0.012) were associated with MCI.

Conclusion

More concentrated efforts focused on early detection and appropriate management of MCI may be required in older Korean adults with type 2 diabetes mellitus.

Citations

Citations to this article as recorded by  
  • Prediction model for mild cognitive impairment in patients with type 2 diabetes using the autonomic function test
    Heeyoung Kang, Juhyeon Kim, Minkyeong Kim, Jin Hyun Kim, Gu Seob Roh, Soo Kyoung Kim
    Neurological Sciences.2024; 45(8): 3757.     CrossRef
  • Association between low cognitive performance and diabetes‐related health indicators across racial and ethnic groups in adults with diabetes
    Piaopiao Li, Khalid Alkhuzam, Joshua Brown, Yichen Zhang, Tianze Jiao, Jingchuan Guo, Guillermo E. Umpierrez, K. M. Venkat Narayan, Ambar Kulshreshtha, Francisco J. Pasquel, Mohammed K. Ali, Hui Shao
    Diabetes, Obesity and Metabolism.2024; 26(9): 3723.     CrossRef
  • Exploration of the Potential and Mechanisms of Diabetic Cognitive Disorder Modulation by Daehwangmokdanpi-tang through a Network Pharmacological Approach
    Yebin Lim, Bitna Kweon, Dong-Uk Kim, Do-Eun Lee, Jungtae Leem, Dong-Gu Kim, Hyung Won Kang, Gi-Sang Bae
    Journal of Korean Medicine.2024; 45(2): 23.     CrossRef
  • Cognitive screening among older adults with diabetes across diverse clinic settings
    Deepashree Gupta, Holly Wilhalme, Gabriela Sauder, Tannaz Moin
    Diabetes Research and Clinical Practice.2023; 196: 110184.     CrossRef
  • Occurrence of mild cognitive impairment with hyperinsulinaemia in Africans with advanced type 2 diabetes mellitus
    J. Bashir, I.U. Yarube
    IBRO Neuroscience Reports.2022; 12: 182.     CrossRef
  • Risk factors for cognitive decline in type 2 diabetes mellitus patients in Brazil: a prospective observational study
    Ana Cristina Ravazzani de Almeida Faria, Joceline Franco Dall’Agnol, Aline Maciel Gouveia, Clara Inácio de Paiva, Victoria Chechetto Segalla, Cristina Pellegrino Baena
    Diabetology & Metabolic Syndrome.2022;[Epub]     CrossRef
  • The TELE-DD project on treatment nonadherence in the population with type 2 diabetes and comorbid depression
    Juan Francisco Roy, María Luisa Lozano del Hoyo, Fernando Urcola-Pardo, Alicia Monreal-Bartolomé, Diana Cecilia Gracia Ruiz, María Mercedes Gómez Borao, Ana Belén Artigas Alcázar, José Pedro Martínez Casbas, Alexandra Aceituno Casas, María Teresa Andaluz
    Scientific Reports.2021;[Epub]     CrossRef
  • Potential roles of Glucagon-like peptide-1 and its analogues in cognitive impairment associated with type 2 diabetes mellitus
    Zi-Wei Yu, Rong Liu, Xin Li, Ying Wang, Yu-Hong Fu, Hui-Yao Li, Yue Yuan, Xin-Yuan Gao
    Mechanisms of Ageing and Development.2020; 190: 111294.     CrossRef
  • Predictors of Quality of Life among Older People with Mild Cognitive Impairment Attending Urban Primary Care Clinics
    Alexander Lourdes Samy, Shahrul Bahyah Kamaruzzaman, Saroja Krishnaswamy, Wah-Yun Low
    Clinical Gerontologist.2020; 43(4): 441.     CrossRef
  • Influence of the Mediterranean and Ketogenic Diets on Cognitive Status and Decline: A Narrative Review
    Federica Vinciguerra, Marco Graziano, Maria Hagnäs, Lucia Frittitta, Andrea Tumminia
    Nutrients.2020; 12(4): 1019.     CrossRef
  • ASSOCIATION BETWEEN CHANGES IN THE PSYCHOLOGICAL STATUS AND METABOLIC DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION, OBESITY AND LEFT VENTRICULAR DIASTOLIC DYSFUNCTION
    N. M. Kyrychenko
    Bulletin of Problems Biology and Medicine.2020; 4(2): 102.     CrossRef
  • Insulin resistance is a risk factor for mild cognitive impairment in elderly adults with T2DM
    Hongjun Zhao, Chenglong Wu, Xiaoping Zhang, Liping Wang, Jianhong Sun, Fuyuan Zhuge
    Open Life Sciences.2019; 14(1): 255.     CrossRef
  • Oral diabetes medication and risk of dementia in elderly patients with type 2 diabetes
    Ju Young Kim, Young Sook Ku, Hyun Jeong Kim, Nga Thi Trinh, Woorim Kim, Bomi Jeong, Tae Young Heo, Myung Koo Lee, Kyung Eun Lee
    Diabetes Research and Clinical Practice.2019; 154: 116.     CrossRef
  • Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies
    Xue Zhao, Qing Han, You Lv, Lin Sun, Xiaokun Gang, Guixia Wang
    Oncotarget.2018; 9(7): 7710.     CrossRef
  • Low education and lack of spousal relationship are associated with dementia in older adults with diabetes mellitus in Nigeria
    Abdulkareem J. Yusuf, Olusegun Baiyewu, Adamu G. Bakari, Sani B. Garko, Mohammed E.‐B. Jibril, Aishatu M. Suleiman, Haruna M. Muktar, Micheal A. Amedu
    Psychogeriatrics.2018; 18(3): 216.     CrossRef
  • Prevalence and risk factors of cognitive dysfunction in patients with type 2 diabetes mellitus receiving care in a reference hospital in Cameroon: a cross-sectional study
    Zainab I. Abba, Yannick Mboue-Djieka, Yacouba N. Mapoure, Cyrille Nkouonlack, Henry N. Luma, Simeon-Pierre Choukem
    International Journal of Diabetes in Developing Countries.2018; 38(2): 158.     CrossRef
  • Cognitive impairment among type 2 diabetes mellitus patients at Jimma University Specialized Hospital, Southwest Ethiopia
    Dagnew Baye, Desalegn Wolide Amare, Mossie Andualem
    Journal of Public Health and Epidemiology.2017; 9(11): 300.     CrossRef
  • Association of metabolic syndrome and 25‐hydroxyvitamin D with cognitive impairment among elderly Koreans
    Eun Young Lee, Su Jin Lee, Kyoung Min Kim, Young Mi Yun, Bo Mi Song, Jong Eun Kim, Hyeon Chang Kim, Yumie Rhee, Yoosik Youm, Chang Oh Kim
    Geriatrics & Gerontology International.2017; 17(7): 1069.     CrossRef
  • Serum uric acid and impaired cognitive function in community-dwelling elderly in Beijing
    Shuangling Xiu, Zheng Zheng, Shaochen Guan, Jin Zhang, Jinghong Ma, Piu Chan
    Neuroscience Letters.2017; 637: 182.     CrossRef
  • Assessment of relationship on excess arsenic intake from drinking water and cognitive impairment in adults and elders in arsenicosis areas
    Jiayong Liu, Yanhui Gao, Hongxu Liu, Jing Sun, Yang Liu, Junhua Wu, Dandan Li, Dianjun Sun
    International Journal of Hygiene and Environmental Health.2017; 220(2): 424.     CrossRef
  • An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia
    Wei Li, Edgar Huang
    Journal of Alzheimer's Disease.2016; 53(2): 393.     CrossRef
  • Current status of managing diabetes mellitus in Korea
    Kyoung Hwa Ha, Dae Jung Kim
    The Korean Journal of Internal Medicine.2016; 31(5): 845.     CrossRef
  • Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort
    Wei Li, Shannon L. Risacher, Edgar Huang, Andrew J. Saykin
    Neurology.2016; 87(6): 595.     CrossRef
  • Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes
    Insa Feinkohl, Markéta Keller, Christine M. Robertson, Joanne R. Morling, Stela McLachlan, Brian M. Frier, Ian J. Deary, Mark W. J. Strachan, Jackie F. Price
    Diabetologia.2015; 58(7): 1637.     CrossRef
  • Association between obesity and depression in patients with diabetes mellitus type 2; a study protocol
    Eduardo De la Cruz-Cano, Carlos Alfonso Tovilla-Zarate, Emilio Reyes-Ramos, Thelma Beatriz Gonzalez-Castro, Isela Juarez-Castro, Maria Lilia López-Narváez, Ana Fresan
    F1000Research.2015; 4: 7.     CrossRef
Role of Glucocorticoid Receptor on Insulin Secretion and Synthesis in INS-1 Cells.
Ju Yeon Yang, Myong Su Kang, Tak Ho Song, In Kook Jeong, Pyong Ju Seo, Hee Jin Kim
Korean Diabetes J. 2006;30(6):428-434.   Published online November 1, 2006
DOI: https://doi.org/10.4093/jkda.2006.30.6.428
  • 1,763 View
  • 30 Download
AbstractAbstract PDF
BACKGROUND
Glucocorticoids play important roles in the regulation of glucose homeostasis. It is well known that glucocorticoids reduce hepatic and peripheral tissue sensitivity to insulin, but the roles of glucocorticoids on insulin secretion and synthesis in pancreatic beta cells are still unclear. We have investigated the direct effects of glucocorticoids on insulin secretion and synthesis in rat insulinoma (INS-1) cells. METHODS: Insulin content and 11.2 mM glucose-stimulated insulin secretion (GSIS) were measured in INS-1 cells after culture with or without 1 micrometer dexamethasone (DEX). Preproinsulin mRNA levels were analyzed by real-time RT-PCR and normalized to the internal control. Effect of RU486 on DEX-induced inhibition of GSIS and preproinsulin mRNA synthesis was evaluated. RESULTS: Insulin content of INS-1 cells cultured in RPMI containing 11.2 mM glucose in the presence of DEX was not different from that of control cells. After 1-h preincubation in 2.8 mM glucose, basal insulin secretion from cells treated with DEX did not differ from that of controls, but GSIS was significantly reduced in the cells treated with DEX in comparison to control cells. The expression of preproinsulin mRNA relative to beta-actin mRNA was also lower in the cells treated with DEX. Glucocorticoid receptor antagonist improved DEX-induced inhibition of GSIS and preproinsulin mRNA synthesis. CONCLUSION: DEX inhibited GSIS and preproinsulin mRNA synthesis in INS-1 cells. Glucocorticoid receptor antagonist ameliorated the reduced GSIS and preproinsulin mRNA synthesis induced by DEX.

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP